First person to receive a genetically modified pig kidney transplant dies almost 2 months later

First recipient of genetically modified pig kidney transplant dies nearly 2 months post-operation. Medical milestone met with tragedy

First Recipient of Genetically Modified Pig Kidney Transplant Dies

 

Richard "Rick" Slayman, the first recipient of a genetically modified pig kidney transplant, has passed away nearly two months after undergoing the groundbreaking procedure at Massachusetts General Hospital in March. Slayman, aged 62, had received the transplant in hopes of addressing complications stemming from kidney failure.

 

The transplant, a pioneering effort in xenotransplantation, aimed to provide a long-term solution to Slayman's renal issues. Surgeons had initially anticipated the genetically modified pig kidney to function effectively for at least two years, offering hope for improved quality of life for Slayman.

 

In a statement released on Saturday, the transplant team at Massachusetts General Hospital expressed profound sadness over Slayman's passing and extended heartfelt condolences to his family. However, they emphasized that there was no indication linking his death to the transplant procedure itself.

 

Slayman's case marked a significant milestone in the field of xenotransplantation, as he became the first living recipient of a genetically modified pig kidney. Previous instances of pig organ transplants involved temporary procedures in brain-dead donors. While two individuals had received heart transplants from pigs, their outcomes were unfortunately short-lived, with both patients succumbing within months.

 

Slayman's medical journey began in 2018 when he underwent a kidney transplant, which initially provided relief. However, complications arose last year, necessitating a return to dialysis. When further complications arose during dialysis, his medical team proposed the innovative approach of a pig kidney transplant as an alternative.

 

Despite Slayman's passing, his case underscores the ongoing advancements in medical science and the potential of xenotransplantation to address critical healthcare needs. While his journey has ended, the legacy of his pioneering spirit and contribution to medical research will endure.